enVVeno Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Net Income	-22.12	-23.52	-24.67	-16.53	-9.74	-7.63	Upgrade
Depreciation & Amortization	0.55	0.55	0.53	0.45	0.38	0.4	Upgrade
Share-Based Compensation	4.52	5.2	8.99	6	0.88	0.94	Upgrade
Other Operating Activities	-0.25	-1.08	-0.47	-1.77	0.19	0.39	Upgrade
Operating Cash Flow	-17.3	-18.86	-15.62	-11.85	-7.68	-5.9	Upgrade
Capital Expenditures	-0.04	-0.03	-0.12	-0.37	-0.18	-0.36	Upgrade
Change in Investments	-8.46	-7.84	-34.44	0	0	0	Upgrade
Investing Cash Flow	-8.5	-7.87	-34.55	-0.37	-0.18	-0.36	Upgrade
Share Issuance / Repurchase	0.05	25.79	0	57.61	13.4	5.64	Upgrade
Debt Issued / Paid	0	0	0	0	0.31	0	Upgrade
Other Financing Activities	-	-	-	-	1.36	-	Upgrade
Financing Cash Flow	0.05	25.79	0	57.61	15.07	5.64	Upgrade
Net Cash Flow	0.04	-0.94	-50.17	45.39	7.22	-0.62	Upgrade
Free Cash Flow	-17.34	-18.89	-15.73	-12.22	-7.86	-6.26	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-20037.42%	Upgrade
Free Cash Flow Per Share	-1.08	-1.54	-1.40	-1.41	-6.08	-9.93	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).